These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38947322)

  • 1. Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunization.
    Ragone C; Mauriello A; Cavalluzzo B; Cavalcanti E; Russo L; Manolio C; Mangano S; Cembrola B; Tagliamonte M; Buonaguro L
    Front Immunol; 2024; 15():1398002. PubMed ID: 38947322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case.
    Manolio C; Ragone C; Cavalluzzo B; Mauriello A; Tornesello ML; Buonaguro FM; Salomone Megna A; D'Alessio G; Penta R; Tagliamonte M; Buonaguro L
    J Transl Med; 2022 Oct; 20(1):472. PubMed ID: 36243758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals.
    Quiros-Fernandez I; Poorebrahim M; Fakhr E; Cid-Arregui A
    EBioMedicine; 2021 Oct; 72():103610. PubMed ID: 34627082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
    Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P
    Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8
    Qiu C; Xiao C; Wang Z; Zhu G; Mao L; Chen X; Gao L; Deng J; Su J; Su H; Fang EF; Zhang ZJ; Zhang J; Xie C; Yuan J; Luo OJ; Huang LA; Wang P; Chen G
    Front Immunol; 2021; 12():764949. PubMed ID: 35116022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
    Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
    Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoinformatics prediction of overlapping CD8
    Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
    Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-A
    Nesterenko PA; McLaughlin J; Tsai BL; Burton Sojo G; Cheng D; Zhao D; Mao Z; Bangayan NJ; Obusan MB; Su Y; Ng RH; Chour W; Xie J; Li YR; Lee D; Noguchi M; Carmona C; Phillips JW; Kim JT; Yang L; Heath JR; Boutros PC; Witte ON
    Cell Rep; 2021 Dec; 37(13):110167. PubMed ID: 34919800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of HLA-A2 restricted CD8
    Deng J; Pan J; Qiu M; Mao L; Wang Z; Zhu G; Gao L; Su J; Hu Y; Luo OJ; Chen G; Wang P
    J Leukoc Biol; 2021 Dec; 110(6):1171-1180. PubMed ID: 34231935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8
    Jin X; Ding Y; Sun S; Wang X; Zhou Z; Liu X; Li M; Chen X; Shen A; Wu Y; Liu B; Zhang J; Li J; Yang Y; Qiu H; Shen C; He Y; Zhao G
    Cell Mol Immunol; 2021 Dec; 18(12):2588-2608. PubMed ID: 34728796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
    Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
    Front Immunol; 2021; 12():692937. PubMed ID: 34497604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research.
    Chen Z; Ruan P; Wang L; Nie X; Ma X; Tan Y
    J Cell Mol Med; 2021 Jan; 25(2):1274-1289. PubMed ID: 33325143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mimicry between tumor associated antigens and microbiota-derived epitopes.
    Ragone C; Manolio C; Mauriello A; Cavalluzzo B; Buonaguro FM; Tornesello ML; Tagliamonte M; Buonaguro L
    J Transl Med; 2022 Jul; 20(1):316. PubMed ID: 35836198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs).
    Ragone C; Manolio C; Cavalluzzo B; Mauriello A; Tornesello ML; Buonaguro FM; Castiglione F; Vitagliano L; Iaccarino E; Ruvo M; Tagliamonte M; Buonaguro L
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.
    Lee E; Sandgren K; Duette G; Stylianou VV; Khanna R; Eden JS; Blyth E; Gottlieb D; Cunningham AL; Palmer S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33443088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains.
    Lee CH; Pinho MP; Buckley PR; Woodhouse IB; Ogg G; Simmons A; Napolitani G; Koohy H
    Front Immunol; 2020; 11():579480. PubMed ID: 33250893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactive CD8
    Cavalluzzo B; Viuff MC; Tvingsholm SA; Ragone C; Manolio C; Mauriello A; Buonaguro FM; Tornesello ML; Izzo F; Morabito A; Hadrup SR; Tagliamonte M; Buonaguro L
    J Exp Clin Cancer Res; 2024 Mar; 43(1):87. PubMed ID: 38509571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses.
    Joag V; Wijeyesinghe S; Stolley JM; Quarnstrom CF; Dileepan T; Soerens AG; Sangala JA; O'Flanagan SD; Gavil NV; Hong SW; Bhela S; Gangadhara S; Weyu E; Matchett WE; Thiede J; Krishna V; Cheeran MC; Bold TD; Amara R; Southern P; Hart GT; Schifanella L; Vezys V; Jenkins MK; Langlois RA; Masopust D
    J Immunol; 2021 Mar; 206(5):931-935. PubMed ID: 33441437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines.
    Reche PA
    Front Immunol; 2020; 11():586984. PubMed ID: 33178220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation.
    Marchan J
    J Immunol Methods; 2022 Mar; 502():113216. PubMed ID: 35007561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.